| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.099 | 0.07 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.07 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.07 |